The Bleeding With Antithrombotic Therapy Study 2

The Bleeding With Antithrombotic Therapy Study 2

The purpose of this study is to determine the incidence and severity of bleeding complications in patients with cerebrovascular and cardiovascular diseases treated with oral antithrombotic therapy.

Inclusion Criteria:

• Patients with cerebrovascular or cardiovascular diseases who start or continue taking oral antithrombotics (antiplatelets and/or anticoagulants) to prevent vascular events
• Patients who are able to receive MRI
• Provision of written informed consent either directly or by a suitable surrogate

Exclusion Criteria:

• MRI contraindication
• Any condition that in the opinion of the responsible physician or investigator that renders the patient unsuitable for the study